A real-world analysis of FDA Adverse Event Reporting System (FAERS) events for liposomal and conventional doxorubicins
Article in Scientific Reports (March 2024)
The most recent citing publications are shown below. View all 61 publications that cite this research output on Dimensions.
A modern view on cardioprotective therapy in cancer patients receiving cardiotoxic chemotherapy
Article in Journal of clinical practice (January 2024)
Anti-tumor therapy of glycyrrhetinic acid targeted liposome co-delivery of doxorubicin and berberine for hepatocellular carcinoma
Article in Drug Delivery and Translational Research (January 2024)